286 related articles for article (PubMed ID: 9288177)
1. Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides.
Tomatis R; Marastoni M; Balboni G; Guerrini R; Capasso A; Sorrentino L; Santagada V; Caliendo G; Lazarus LH; Salvadori S
J Med Chem; 1997 Aug; 40(18):2948-52. PubMed ID: 9288177
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and opioid activity of tyrosine sulfate containing dermorphin and deltorphin peptides.
Marastoni M; Salvadori S; Balboni G; Scaranari V; Borea PA; Tomatis A
Arzneimittelforschung; 1995 Feb; 45(2):116-9. PubMed ID: 7710429
[TBL] [Abstract][Full Text] [Related]
3. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and activity profiles of new dermorphin-(1-4) peptide analogues.
Marastoni M; Salvadori S; Balboni G; Borea PA; Marzola G; Tomatis R
J Med Chem; 1987 Sep; 30(9):1538-42. PubMed ID: 2887656
[TBL] [Abstract][Full Text] [Related]
5. Dermorphin tetrapeptide analogues with 2',6'-dimethylphenylalanine (Dmp) substituted for aromatic amino acids have high mu opioid receptor binding and biological activities.
Ambo A; Niizuma H; Sasaki A; Kohara H; Sasaki Y
Bioorg Med Chem Lett; 2003 Apr; 13(7):1269-72. PubMed ID: 12657261
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and opioid activity of dermorphin tetrapeptides bearing D-methionine S-oxide at position 2.
Salvadori S; Marastoni M; Balboni G; Sarto GP; Tomatis R
J Med Chem; 1986 Jun; 29(6):889-94. PubMed ID: 2872334
[TBL] [Abstract][Full Text] [Related]
7. Opioid peptides. Structure-activity relationships of dermorphin endothiotetrapeptides. VII.
Salvadori S; Marastoni M; Balboni G; Tomatis R; Sarto G
Farmaco Sci; 1984 Apr; 39(4):316-21. PubMed ID: 6144571
[TBL] [Abstract][Full Text] [Related]
8. Dermorphin and deltorphin glycosylated analogues: synthesis and antinociceptive activity after systemic administration.
Negri L; Lattanzi R; Tabacco F; Orrù L; Severini C; Scolaro B; Rocchi R
J Med Chem; 1999 Feb; 42(3):400-4. PubMed ID: 9986710
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, conformation and biological activity of dermorphin and deltorphin I analogues containing N-alkylglycine in place of residues in position 1, 3, 5 and 6.
Biondi L; Giannini E; Filira F; Gobbo M; Marastoni M; Negri L; Scolaro B; Tomatisc R; Rocchi R
J Pept Sci; 2003 Oct; 9(10):638-48. PubMed ID: 14620129
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers.
Schiller PW; Nguyen TM; Lemieux C; Maziak LA
J Med Chem; 1985 Dec; 28(12):1766-71. PubMed ID: 2999401
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological activity of the N-terminal dermorphin tetrapeptide analogs with CH2-NH peptide bond isosteres.
Salvadori S; Guerrini R; Borea PA; Tomatis R
Int J Pept Protein Res; 1992 Nov; 40(5):437-44. PubMed ID: 1362392
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biochemical and pharmacological properties of BUBUC, a highly selective and systemically active agonist for in vivo studies of delta-opioid receptors.
Gacel GA; Fellion E; Baamonde A; Dauge V; Roques BP
Peptides; 1990; 11(5):983-8. PubMed ID: 1980943
[TBL] [Abstract][Full Text] [Related]
13. Potent side-chain to side-chain cyclized dermorphin analogues containing a carbonyl bridge.
Filip K; Oleszczuk M; Pawlak D; Wojcik J; Chung NN; Schillerc PW; Izdebski J
J Pept Sci; 2003 Oct; 9(10):649-57. PubMed ID: 14620130
[TBL] [Abstract][Full Text] [Related]
14. Opioid deltorphin C analogues containing cis- or trans-2- or 3- or 4-aminocyclohexanecarboxylic acid residues.
Marastoni M; Guerrini R; Balboni G; Salvadori S; Fantin G; Fogagnolo M; Lazarus LH; Tomatis R
Arzneimittelforschung; 1999 Jan; 49(1):6-12. PubMed ID: 10028372
[TBL] [Abstract][Full Text] [Related]
15. Conformationally restricted deltorphin analogues.
Schiller PW; Weltrowska G; Nguyen TM; Wilkes BC; Chung NN; Lemieux C
J Med Chem; 1992 Oct; 35(21):3956-61. PubMed ID: 1331451
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of deltorphin analogues.
Salvadori S; Marastoni M; Balboni G; Borea PA; Morari M; Tomatis R
J Med Chem; 1991 May; 34(5):1656-61. PubMed ID: 1851843
[TBL] [Abstract][Full Text] [Related]
17. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
[TBL] [Abstract][Full Text] [Related]
18. Selective opioid dipeptides.
Temussi PA; Salvadori S; Amodeo P; Bianchi C; Guerrini R; Tomatis R; Lazarus LH; Picone D; Tancredi T
Biochem Biophys Res Commun; 1994 Feb; 198(3):933-9. PubMed ID: 8117299
[TBL] [Abstract][Full Text] [Related]
19. Single diastereomeric desaminotyrosylalanyl tetra- and heptapeptides with opioid antagonistic activity.
Balboni G; Salvadori S; D'Angeli F; Marchetti P; Lazarus LH; Bryant SD; Bianchi C
Int J Pept Protein Res; 1995 Feb; 45(2):187-93. PubMed ID: 7782167
[TBL] [Abstract][Full Text] [Related]
20. Dermenkephalin and deltorphin I reveal similarities within ligand-binding domains of mu- and delta-opioid receptors and an additional address subsite on the delta-receptor.
Charpentier S; Sagan S; Delfour A; Nicolas P
Biochem Biophys Res Commun; 1991 Sep; 179(3):1161-8. PubMed ID: 1656944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
